FIIMX
Price
$23.90
Change
-$0.37 (-1.52%)
Updated
Sep 6 closing price
VIMAX
Price
$308.33
Change
-$3.72 (-1.19%)
Updated
Sep 6 closing price
Ad is loading...

FIIMX vs VIMAX

Header iconFIIMX vs VIMAX Comparison
Open Charts FIIMX vs VIMAXBanner chart's image
Fidelity Advisor Mid Cap II I
Price$23.90
Change-$0.37 (-1.52%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$308.33
Change-$3.72 (-1.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FIIMX vs VIMAX Comparison Chart
Loading...
VS
FIIMX vs. VIMAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIIMX is a Hold and VIMAX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 172B vs. FIIMX (1.56B). VIMAX pays higher dividends than FIIMX: VIMAX (1.49) vs FIIMX (0.35). FIIMX was incepted earlier than VIMAX: FIIMX (20 years) vs VIMAX (23 years). FIIMX is a more actively managed with annual turnover of: 47.00 vs. VIMAX (13.00). FIIMX has a lower initial minimum investment than VIMAX: FIIMX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.94 vs. FIIMX (14.88). VIMAX return over 5 years is better than : 51.92 vs. FIIMX (32.01).
FIIMXVIMAXFIIMX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD9.1778.498108%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B172B1%
Annual Yield % from dividends0.351.4924%
Returns for 1 year14.8815.9493%
Returns for 3 years-9.241.69-545%
Returns for 5 years32.0151.9262%
Returns for 10 years10.72114.299%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KORE2.430.22
+9.95%
KORE Group Holdings
USPH86.78N/A
N/A
US Physical Therapy
SENEA60.13-0.33
-0.55%
Seneca Foods Corp
REGN1150.65-28.72
-2.44%
Regeneron Pharmaceuticals
TNET97.19-2.60
-2.61%
Trinet Group